Microfluidic Mitochondria Transfer for Dysfunctional Immune Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively address the variability in immune cell subpopulations for potent cancer therapy by not considering the health and stability of immune cell mitochondria, which are crucial for immune function.
Innovation Solution
A microfluidic system is used to transplant functional mitochondria from healthy immune cells to dysfunctional ones, enhancing immune cell functionality through mitochondrial transplantation, and includes genomic, transcriptomic, and proteomic analysis to identify and edit mitochondrial and genomic sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If mitochondrial transplantation is performed to improve immune cell function, then immune cell activity and anti-tumor response are enhanced, but device complexity and manufacturing difficulty increase due to the need for microfluidic systems and single-cell manipulation
Solution Approach 1:
The patent uses microfluidic droplets as intermediary carriers to facilitate mitochondrial transplantation. The droplets serve as controlled microenvironments that enable precise delivery of mitochondria to target immune cells, resolving the contradiction by providing a manageable intermediary system rather than direct complex manipulation
Solution Approach 2:
The patent segments the immune cell population into individual single cells within separate microfluidic droplets. This segmentation allows for precise, cell-by-cell mitochondrial transplantation and functional analysis, enabling high-throughput screening while maintaining simple operational protocols for each individual cell-droplet unit
2Measurement precision
If comprehensive genomic, transcriptomic, and proteomic analysis is conducted to identify mitochondrial dysfunction, then measurement precision and diagnostic accuracy improve, but loss of time and analytical complexity increase
Solution Approach 1:
The patent performs preliminary sorting and isolation of immune cells with dysfunctional mitochondria using microfluidic techniques before conducting comprehensive omics analysis. This preliminary action enriches the sample population, reducing the time and resources needed for subsequent genomic, transcriptomic, and proteomic analyses by focusing only on relevant cells
Solution Approach 2:
The patent employs dynamic, multi-omics analysis that can be adapted and scaled based on specific research needs. The system allows for flexible combination of genomic, transcriptomic, and proteomic analyses, enabling researchers to adjust the depth and breadth of analysis dynamically based on available resources and time constraints
Data Source
AI summary
Methods and systems are provided for analyzing the ability of immune cells to kill target cells based on the effectiveness of mitochondria of the immune cells. The systems and methods further can be used for transplanting healthy mitochondria into immune cells to increase their effectiveness against target cells. The methods described herein can be used in treatment of cancer, mitochondrial diseases, and certain metabolic diseases.